Related by context. Frequent words. (Click for all words.) 78 Copegus R 74 Powerwave logo 73 Medarex logo 72 Advancing Drugs 72 InfiniPCI 70 PDL BioPharma logo 70 TELINTRA 69 Kuvan R 69 * Azixa 69 NOTE PDL BioPharma 68 Theravance logo 68 SPECTRUM PHARMACEUTICALS INC. 68 UltiMAb R 67 MEDICINES THAT MAKE 67 InfiniHost InfiniRISC InfiniScale 67 DAVANAT 66 2 methoxyestradiol 66 Aurexis 66 Powerwave Powerwave Technologies 66 PEG PAL PEGylated recombinant 66 Initiates Phase II 66 Pegasys ® 66 phenylalanine ammonia lyase 66 Panzem R 65 Integration BEA WebLogic 65 Receives Orphan Drug Designation 65 refractory chronic lymphocytic 65 R sorafenib tablets 65 Oral Suspension Oral Suspension 65 topical non steroidal 65 Inhalation Aerosol 65 inflammatory autoimmune diseases 64 CHEAP ONLINE PHARMACY LOW 64 Veronate 64 HepeX B 64 Alferon N Injection 64 products Oncaspar 64 MKC# 64 Palifosfamide 64 immuno inflammatory diseases 64 ALN TTR 64 CONTAINS FORWARD LOOKING STATEMENTS 64 peripherally acting 64 Traficet EN 64 Recombinant Human 64 Juniper Networks logo 64 KNS # 64 Kepivance 64 huC# DM4 64 copyrights contained herein 64 Completes Enrollment 63 Portal BEA WebLogic 63 Release Tablets 63 inflammatory autoimmune 63 ARE ONLY PREDICTIONS 63 Onalta 63 JAK1 63 Epidermal Growth Factor Receptor 63 TRANSDUR Sufentanil 63 targeting CD# 63 Meets Primary Endpoint 63 anticancer compounds 63 LHF Seven Summits Strategic 63 CHEAP ONLINE PHARMACY BEST 63 Xyntha 63 TH STAFF WRITER 63 humanized monoclonal antibody 63 Alinia 63 RHF Seven Summits Strategic 63 Inc Therapeutic Competitors 63 ARE MADE AS 63 non alcoholic steatohepatitis 63 XEROX CORPORATION 63 aesthetic medicine BioLook 63 phenylketonuria PKU developed 62 Factor VIIa 62 Interferons 62 shaped Genmab 62 dermatological disorders 62 Amplimexon 62 AzaSite Plus 62 IS NOT INDICATIVE OF 62 F. PARTLOW 62 Commences Phase 62 SARMs 62 PRICES GREAT DISCOUNTS 62 Rebif ® 62 Platform BEA WebLogic 62 BiTE R 62 cutaneous T 62 news.de ein Presseportal der 62 R MUDD R 62 Belimumab 62 Injectable Suspension 62 STATEMENT AND OTHER DOCUMENTS 62 NanoSemiconductor Company 62 BY STEPHANIE A. WILKEN 62 THE REPORTING 62 novel antibody therapeutics 62 Omigard TM 62 Gemzar ®